Formulation development
The Formulation Development department has dealt with over one hundred marketed products.
Thanks to its full-service capability (from analytical characterization of the active compound through to industrial scale-up) or specific project tasks (trial batch manufacturing, analytical validation, clinical packaging, etc.), our multidisciplinary team can design simple or innovative, more complex solutions.
With over 20 years of experience and a team of expert pharmacist and engineers, the Formulation Department offers a broad range of services and technologies for producing the following type of formulation:
DRY FORMULATIONS: batches from 0.5 to 50 kg
- tablets (coated or non-coated)
- semi-automated or automated capsule filling with pre-compression
- sachets of powders
- powder sticks
- dry mixing and dry or wet granulation processes
LIQUID FORMULATIONS: from 0.1 to 50 l or kg
- drinkable oral solutions and suspensions
- liquid stick packs
- creams, gels, ointments
PLACEBOS
In some clinical trials, the study drug is compared with a placebo. Unither develops and produces all types of placebo in solid or liquid formulations and also performs ICH stability studies.
MASKED TABLETS
For double-blind, comparative clinical trials, Unither can produce batches of masked tablets. It can also develop dissolution methods and perform ICH stability studies.
PRIMARY PACKAGING
- blister packs: PVC/ALU, PVC-PVDC/ALU, ALU/ALU, Aclar, Triplex, etc.
- sachets
- rigid tubes, flexible HDPE tubes, aluminium tubes
- pillboxes
- flasks and bottles
Types of equipment
Coating in perforated or non-perforated pans
Compacting in dual-motion or rotary presses
Semi-automated or automated capsule filling with pre-compacting
Mixing tanks for liquids and pastes, vacuum jacketed tank
Blister and sachet packing, tube filling
All items of equipment have been qualified
Premises
Four manufacturing suites and a development suite.
Climate control.
Prevention of cross-contamination thanks to use of an independent clean air supply system for each suite and a corridor/suite overpressure airlock.
The premises have been qualified for manufacturing operations.